XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,096,535 | -77.8% | 178,470 | -75.0% | 0.03% | -76.9% |
| Q2 2023 | $27,430,403 | -22.3% | 712,478 | -27.8% | 0.12% | -32.8% |
| Q1 2023 | $35,295,919 | -24.9% | 986,195 | -17.2% | 0.17% | -39.4% |
| Q4 2022 | $46,986,286 | -28.8% | 1,191,638 | -34.9% | 0.29% | -32.0% |
| Q3 2022 | $66,032,000 | +18.7% | 1,829,152 | 0.0% | 0.42% | +25.6% |
| Q2 2022 | $55,643,000 | +100.1% | 1,829,152 | +101.1% | 0.34% | +131.7% |
| Q1 2022 | $27,807,000 | – | 909,628 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |